//
N. Suresh - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Pancreas ductal adenocarcinoma
N/A
R. Ibrahim - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021
Therapeutic Area
Disease
Drug/Treatment
N/A
N/A
N/A
N. Manu - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Klatskin tumors
N/A
A. Hann - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Thrombocytopenia
N/A
K. Ammar - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021
Therapeutic Area
Disease
Drug/Treatment
Gastroenterology (GU)
Pancreatitis
N/A
E. Jerome - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Colorectal liver metastases
N/A
J. Sijberden - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021
Therapeutic Area
Disease
Drug/Treatment
N/A
N/A
N/A
E. Jerome - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Secondary liver cancer
Oxaliplatin, 5-fluorouracil and folic acid
E. Jerome - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Liver cancer
N/A
S. Aroori - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021
Therapeutic Area
Disease
Drug/Treatment
N/A
N/A
N/A
S. Biggs - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021
Therapeutic Area
Disease
Drug/Treatment
N/A
N/A
N/A
T.B. Russell - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Pancreatic cancer
N/A
P. Estridge - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021
Therapeutic Area
Disease
Drug/Treatment
N/A
N/A
N/A
Constantin-Cristian Topriceanu - British Cardiovascular Society (BCS) , 2021
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Hypertrophic cardiomyopathy
N/A
Anenta Ramakrishnan - British Cardiovascular Society (BCS) , 2021
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Left ventricular hypertrophy
N/A
Joyee Basu - British Cardiovascular Society (BCS) , 2021
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Hypertrophic cardiomyopathy
N/A
Harish Sharma - British Cardiovascular Society (BCS) , 2021
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Mitral valve regurgitation
N/A
Zaid Iskandar - British Cardiovascular Society (BCS) , 2021
Therapeutic Area
Disease
Drug/Treatment
Musculoskeletal
Marfan syndrome
N/A
Thomas Rance - British Cardiovascular Society (BCS) , 2021
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Hypertrophic cardiomyopathy
N/A
Laxmi Kaliyappan - British Cardiovascular Society (BCS) , 2021
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Hypertrophic cardiomyopathy
N/A